Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
11 05 2023
Historique:
received: 05 04 2023
revised: 05 05 2023
accepted: 08 05 2023
medline: 29 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

The introduction of direct-acting antivirals (DAAs) has revolutionized hepatitis C treatment. Short courses of treatment with these drugs are highly beneficial to patients, eliminating hepatitis C virus (HCV) without adverse effects. However, this outstanding success is tempered by the continuing difficulty of eradicating the virus worldwide. Thus, access to an effective vaccine against HCV is strongly needed to reduce the burden of the disease and contribute to the elimination of viral hepatitis. The recent failure of a T-cell vaccine based on the use of viral vectors expressing the HCV non-structural protein sequences to prevent chronic hepatitis C in drug users has pointed out that the induction of neutralizing antibodies (NAbs) will be essential in future vaccine candidates. To induce NAbs, vaccines must contain the main target of this type of antibody, the HCV envelope glycoproteins (E1 and E2). In this review, we summarize the structural regions in E1 and E2 proteins that are targeted by NAbs and how these proteins are presented in the vaccine candidates currently under development.

Identifiants

pubmed: 37243237
pii: v15051151
doi: 10.3390/v15051151
pmc: PMC10220683
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Viral Envelope Proteins 0
Antiviral Agents 0
Viral Hepatitis Vaccines 0
Hepatitis C Antibodies 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Proc Natl Acad Sci U S A. 2019 May 14;116(20):10039-10047
pubmed: 31040211
J Hepatol. 2020 Apr;72(4):670-679
pubmed: 31785346
J Virol. 2015 Feb;89(4):2170-81
pubmed: 25473061
J Virol. 2016 Jan 27;90(7):3773-82
pubmed: 26819308
Hepatology. 2016 Jul;64(1):130-7
pubmed: 26946190
J Virol. 2012 Mar;86(5):2739-49
pubmed: 22171278
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9499-504
pubmed: 22623528
Elife. 2020 Mar 03;9:
pubmed: 32125272
Sci Rep. 2018 Apr 24;8(1):6483
pubmed: 29691437
Sci Transl Med. 2012 Jan 4;4(115):115ra1
pubmed: 22218690
N Engl J Med. 2021 Feb 11;384(6):541-549
pubmed: 33567193
Front Immunol. 2022 Jun 28;13:831285
pubmed: 35837406
Virology. 2001 Jan 5;279(1):58-68
pubmed: 11145889
J Biol Chem. 2020 May 22;295(21):7179-7192
pubmed: 32299914
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176
pubmed: 28404132
PLoS One. 2008;3(12):e3942
pubmed: 19079604
Hepatology. 2019 Feb;69(2):513-523
pubmed: 30125371
J Gen Virol. 2007 Nov;88(Pt 11):2991-3001
pubmed: 17947521
Sci Adv. 2019 Jan 02;5(1):eaav1882
pubmed: 30613781
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Viruses. 2021 Jul 13;13(7):
pubmed: 34372558
J Biol Chem. 2015 Apr 17;290(16):10117-25
pubmed: 25737449
J Gen Virol. 1999 Apr;80 ( Pt 4):887-896
pubmed: 10211957
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6205-10
pubmed: 22492964
J Mol Biol. 2013 Jun 12;425(11):1899-1914
pubmed: 23458406
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2112008119
pubmed: 35263223
Science. 2022 Oct 21;378(6617):263-269
pubmed: 36264808
J Infect Dis. 2010 Sep 15;202(6):862-6
pubmed: 20677942
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12768-12773
pubmed: 27791120
JCI Insight. 2017 May 4;2(9):
pubmed: 28469084
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6025-30
pubmed: 17392433
J Virol. 2013 Jan;87(1):37-51
pubmed: 23097455
PLoS Pathog. 2017 Dec 18;13(12):e1006735
pubmed: 29253863
Hepatology. 2016 Apr;63(4):1120-34
pubmed: 26710081
Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1294-8
pubmed: 7509068
Liver Int. 2020 Mar;40(3):522-529
pubmed: 31815353
Hepatology. 2017 Apr;65(4):1117-1131
pubmed: 27997681
MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1011-1017
pubmed: 35951484
Gastroenterology. 2016 Jan;150(1):206-217.e4
pubmed: 26404951
Hepatology. 2004 Jun;39(6):1709-20
pubmed: 15185313
Lancet. 2019 Mar 30;393(10178):1319-1329
pubmed: 30704789
Nature. 2021 Oct;598(7881):521-525
pubmed: 34526719
J Virol. 2018 Apr 13;92(9):
pubmed: 29467319
Hepatology. 2016 Dec;64(6):1881-1892
pubmed: 27351277
J Virol. 2016 Nov 14;90(23):10486-10498
pubmed: 27630242
Virology. 2014 Jan 5;448:229-37
pubmed: 24314653
EMBO J. 2002 Oct 1;21(19):5017-25
pubmed: 12356718
Hepatology. 2002 Nov;36(5 Suppl 1):S21-9
pubmed: 12407573
Hepatology. 2014 Jan;59(1):24-34
pubmed: 23775920
Gastroenterology. 2017 Oct;153(4):996-1005.e1
pubmed: 28642197
Hepatology. 2014 Jan;59(1):318-27
pubmed: 24115039
J Virol. 2018 May 14;92(11):
pubmed: 29540595
Cell Rep. 2022 May 24;39(8):110859
pubmed: 35613596
Microb Cell Fact. 2016 Apr 13;15:62
pubmed: 27075377
Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6
pubmed: 12761383
J Hepatol. 2014 Nov;61(1 Suppl):S79-90
pubmed: 25443348
PLoS One. 2013;8(3):e59776
pubmed: 23527266
J Biol Chem. 2000 Oct 6;275(40):31428-37
pubmed: 10807921
J Virol. 2019 Jun 28;93(14):
pubmed: 31068427
J Virol. 2012 Dec;86(23):13085-8
pubmed: 22973046
Nat Commun. 2023 Jan 26;14(1):433
pubmed: 36702826
J Virol. 2004 Jul;78(13):7257-63
pubmed: 15194801
Virology. 2018 Jan 15;514:30-41
pubmed: 29128754
Curr Opin Virol. 2013 Jun;3(3):357-62
pubmed: 23731601
Hepatology. 2020 May;71(5):1845-1850
pubmed: 32060946
J Gen Virol. 1997 Sep;78 ( Pt 9):2299-306
pubmed: 9292018
J Hepatol. 2017 Sep 05;:
pubmed: 28887168
PLoS One. 2016 Oct 24;11(10):e0165047
pubmed: 27776169
Front Immunol. 2018 Jun 11;9:1315
pubmed: 29951061
Open Forum Infect Dis. 2019 Feb 22;6(3):ofz076
pubmed: 30949527
J Infect Dis. 2011 Sep 1;204(5):811-3
pubmed: 21788452
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
pubmed: 19234466
Hepatology. 2011 Oct;54(4):1149-56
pubmed: 21735466
J Hepatol. 2017 Sep;67(3):480-489
pubmed: 28438690
Hepatology. 2015 Oct;62(4):1059-69
pubmed: 25820616
Gastroenterology. 2010 Jan;138(1):315-24
pubmed: 19782080
J Virol. 2012 Dec;86(23):12923-32
pubmed: 22993159
Clin Infect Dis. 2016 Mar 15;62(6):683-694
pubmed: 26787172
J Virol. 2006 Feb;80(4):1688-99
pubmed: 16439526
Nat Commun. 2014 Sep 16;5:4874
pubmed: 25224686
J Biol Chem. 2003 Oct 24;278(43):41624-30
pubmed: 12913001
J Virol. 2008 Jan;82(2):966-73
pubmed: 17977972
PLoS Pathog. 2014 Aug 14;10(8):e1004297
pubmed: 25122476
mBio. 2017 May 16;8(3):
pubmed: 28512091
Trends Microbiol. 2014 Apr;22(4):176-82
pubmed: 24569295
Sci Transl Med. 2014 Sep 17;6(254):254ra129
pubmed: 25232181
J Hepatol. 2019 Apr;70(4):593-602
pubmed: 30439392
J Virol. 1999 Aug;73(8):6235-44
pubmed: 10400713
J Virol. 2008 Jun;82(12):6061-6
pubmed: 18400849
Sci Adv. 2020 Apr 15;6(16):eaaz6225
pubmed: 32494617
J Hepatol. 2022 May;76(5):1051-1061
pubmed: 34990750
J Virol. 2015 Dec;89(24):12245-61
pubmed: 26378182
J Hepatol. 2020 Nov;73(5):1170-1218
pubmed: 32956768
Nat Med. 2008 Jan;14(1):25-7
pubmed: 18064037
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15394-9
pubmed: 8986822
J Virol. 2019 Oct 29;93(22):
pubmed: 31462563
Gastroenterology. 2022 Feb;162(2):562-574
pubmed: 34655573
Curr Top Microbiol Immunol. 2013;369:113-42
pubmed: 23463199
PLoS Pathog. 2013;9(5):e1003364
pubmed: 23696737
PLoS One. 2016 Mar 11;11(3):e0151626
pubmed: 26966906
Hepatology. 2006 Mar;43(3):592-601
pubmed: 16496330
Hepatology. 2013 Apr;57(4):1303-13
pubmed: 23150224
J Gen Virol. 2001 Aug;82(Pt 8):1877-1883
pubmed: 11457993
J Infect Dis. 2017 Jun 15;215(12):1824-1831
pubmed: 28398489
J Virus Erad. 2017 Jul 1;3(3):117-123
pubmed: 28758018
J Clin Invest. 2021 Jan 19;131(2):
pubmed: 33463551
Antiviral Res. 2017 Dec;148:53-64
pubmed: 29074219
J Hepatol. 2014 Nov;61(1 Suppl):S58-68
pubmed: 25443346
Gut. 2016 Dec;65(12):1988-1997
pubmed: 26589670
J Infect Dis. 2018 Oct 20;218(11):1722-1729
pubmed: 29982508
Hepatology. 1994 May;19(5):1321-4
pubmed: 8175159
J Virol. 2015 Oct;89(20):10333-46
pubmed: 26246575
J Virol. 1994 Oct;68(10):6147-60
pubmed: 8083956
J Gen Virol. 2011 Mar;92(Pt 3):494-506
pubmed: 21084495
Immunity. 2022 Feb 8;55(2):341-354.e7
pubmed: 34990590
Vaccine. 2018 Apr 19;36(17):2273-2281
pubmed: 29576303
J Virol. 2008 Apr;82(7):3555-60
pubmed: 18234789
Sci Transl Med. 2011 Aug 3;3(94):94ra71
pubmed: 21813755
Nat Med. 2006 Feb;12(2):190-7
pubmed: 16462801
Nat Commun. 2022 Nov 25;13(1):7271
pubmed: 36434005
J Virol. 2011 Oct;85(20):10451-63
pubmed: 21813602
Gut. 2021 Sep;70(9):1734-1745
pubmed: 33323394
J Viral Hepat. 2006 Jan;13(1):34-41
pubmed: 16364080
J Virol. 2010 Jun;84(11):5751-63
pubmed: 20357091
PLoS Pathog. 2012;8(4):e1002653
pubmed: 22511875
J Infect Dis. 2020 Mar 28;221(8):1304-1314
pubmed: 31074790
J Infect Dis. 2011 Oct 15;204(8):1186-90
pubmed: 21917891
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Gastroenterology. 2020 Mar;158(4):1058-1071.e6
pubmed: 31809725
Cell Host Microbe. 2018 Nov 14;24(5):703-716.e3
pubmed: 30439340
Sci Rep. 2016 Feb 22;6:21808
pubmed: 26898231
Nature. 2014 May 15;509(7500):381-4
pubmed: 24553139
Proc Natl Acad Sci U S A. 2007 May 15;104(20):8449-54
pubmed: 17494735
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16269-74
pubmed: 17911260
Virology. 2014 Jun;458-459:190-208
pubmed: 24928051
Sci Rep. 2019 Jun 25;9(1):9251
pubmed: 31239471
J Clin Invest. 2015 Jan;125(1):437-47
pubmed: 25500884
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E6946-E6954
pubmed: 27791171
Hepatology. 2014 Mar;59(3):776-88
pubmed: 24038151
Nat Med. 2005 Jul;11(7):791-6
pubmed: 15951748
Vaccines (Basel). 2020 Jun 10;8(2):
pubmed: 32532076
Hepatology. 2006 Nov;44(5):1355-61
pubmed: 17058236
J Virol. 1997 Jan;71(1):697-704
pubmed: 8985401
Antiviral Res. 2018 Dec;160:25-37
pubmed: 30217650
Science. 2013 Nov 29;342(6162):1090-4
pubmed: 24288331
J Clin Invest. 2019 Aug 13;129(11):4786-4796
pubmed: 31408439
PLoS Pathog. 2012;8(8):e1002895
pubmed: 22952447
PLoS One. 2011 Mar 30;6(3):e16857
pubmed: 21479208
Gut. 2023 Mar;72(3):560-572
pubmed: 35918103
J Virol. 2000 Apr;74(8):3623-33
pubmed: 10729138
Gut. 2018 Feb;67(2):372-379
pubmed: 27797937
J Virol. 2006 Sep;80(17):8695-704
pubmed: 16912317
Sci Transl Med. 2014 Nov 5;6(261):261ra153
pubmed: 25378645
J Viral Hepat. 2017 Oct;24(10):850-857
pubmed: 28345206
Liver Int. 2020 Aug;40(8):1865-1871
pubmed: 32458507
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2706-11
pubmed: 14981267
Gut. 2019 Jan;68(1):140-149
pubmed: 29180585
J Virol. 2014 Nov;88(21):12644-55
pubmed: 25142595
Biochem Pharmacol. 2016 Nov 15;120:1-14
pubmed: 27157411
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 May;13(3):e1681
pubmed: 33164326
Vaccine. 2020 Oct 14;38(44):6864-6867
pubmed: 32900542
Transfusion. 2005 Jun;45(6):994-1002
pubmed: 15934999
BMC Infect Dis. 2019 Nov 5;19(1):932
pubmed: 31690267
Virology. 2018 Jun;519:33-41
pubmed: 29631174
Gastroenterology. 2013 Aug;145(2):447-55.e1-4
pubmed: 23673355
J Mol Biol. 2015 Aug 14;427(16):2617-28
pubmed: 26135247
Hepatology. 2016 Dec;64(6):1922-1933
pubmed: 27641232
J Gen Virol. 2016 Aug;97(8):1865-1876
pubmed: 27147296
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):
pubmed: 33431677
Science. 1998 Oct 30;282(5390):938-41
pubmed: 9794763
Sci Rep. 2021 Nov 8;11(1):21856
pubmed: 34750487
Hepatology. 2014 Jun;59(6):2140-51
pubmed: 24425349
J Virol. 2010 Nov;84(22):11905-15
pubmed: 20844034
Vaccine. 2015 Feb 18;33(8):973-6
pubmed: 25596457
J Virol. 2010 Oct;84(19):10159-68
pubmed: 20668082
J Virol. 2019 Feb 5;93(4):
pubmed: 30487284
Front Immunol. 2018 May 31;9:1194
pubmed: 29904384
J Virol. 2009 Dec;83(23):12473-82
pubmed: 19759151
PLoS Pathog. 2019 May 22;15(5):e1007759
pubmed: 31116791
Infect Genet Evol. 2017 Apr;49:88-96
pubmed: 28065804
Sci Rep. 2017 Mar 16;7(1):214
pubmed: 28303031
J Hepatol. 2019 Dec;71(6):1099-1105
pubmed: 31400349
J Hepatol. 2016 May;64(5):1020-1026
pubmed: 26780289
Vaccine. 2010 Aug 31;28(38):6367-73
pubmed: 20619382
N Biotechnol. 2009 Apr;25(4):226-34
pubmed: 19356608
Vaccine. 2019 May 1;37(19):2608-2616
pubmed: 30962092
J Virol. 2016 Jan 06;90(6):3112-22
pubmed: 26739044
J Virol. 2017 Mar 29;91(8):
pubmed: 28148799
PLoS One. 2016 May 25;11(5):e0156213
pubmed: 27224423
J Virol. 2007 Aug;81(15):8030-40
pubmed: 17522229
J Virol. 2007 Mar;81(5):2372-81
pubmed: 17166909

Auteurs

Elsa Gomez-Escobar (E)

Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France.

Philippe Roingeard (P)

Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France.

Elodie Beaumont (E)

Inserm U1259 MAVIVH, Université de Tours and CHRU de Tours, 37000 Tours, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH